Miyake A, Mochizuki S, Kawashima H
Molecular Medicine Research Laboratories, Yamanouchi Institute for Drug Discovery Research, Ibaraki, Japan.
Biochem Pharmacol. 1994 Apr 20;47(8):1339-43. doi: 10.1016/0006-2952(94)90332-8.
The cholecystokinin (CCK)-B receptor cloned from human brain was characterized as a gastrin receptor by using heterologous expression systems of COS-7 cells and Xenopus oocytes. 125I-gastrin binding to human CCK-B receptor expressed in COS-7 was time-dependent, saturable and also specific, as well as 125-I-CCK-8. The binding of 125I-gastrin was inhibited by CCK-8 about 10-fold more potently than by gastrin. The rank order of potency of several antagonists to 125I-gastrin binding was YM022 > CI-988 > L-365,260 > L-364,718. Addition of GTP gamma S, a nonhydrolysable analog of GTP, dose-dependently inhibited 125I-gastrin binding, and lowered the gastrin binding affinity, Gastrin (10(-9)-10(-7) M) also evoked a Ca(2+)-dependent Cl- current in Xenopus oocytes expressing CCK-B receptors. These results suggest that the pharmacological profile of the cloned human CCK-B receptor using 125I-gastrin is closely parallel to that reported in gastric mucosa, and that the receptor transduces cellular signals of gastrin as well as those of CCK-8.
通过使用COS-7细胞和非洲爪蟾卵母细胞的异源表达系统,从人脑中克隆的胆囊收缩素(CCK)-B受体被鉴定为胃泌素受体。125I-胃泌素与COS-7细胞中表达的人CCK-B受体的结合具有时间依赖性、饱和性和特异性,125I-CCK-8也是如此。CCK-8对125I-胃泌素结合的抑制作用比胃泌素强约10倍。几种拮抗剂对125I-胃泌素结合的效价顺序为YM022 > CI-988 > L-365,260 > L-364,718。添加GTPγS(一种不可水解的GTP类似物)可剂量依赖性地抑制125I-胃泌素结合,并降低胃泌素结合亲和力。胃泌素(10^(-9)-10^(-7) M)也能在表达CCK-B受体的非洲爪蟾卵母细胞中诱发Ca(2+)依赖性Cl-电流。这些结果表明,使用125I-胃泌素时,克隆的人CCK-B受体的药理学特征与胃黏膜中报道的特征密切平行,并且该受体可转导胃泌素以及CCK-8的细胞信号。